We are pleased to announce that effective 1 April 2008, Fourth Hurdle Consulting Ltd., has become part of IMS Health.
Health Economics and Outcomes Research (HEOR) is a key growth area for IMS and this exciting addition to the business will enable us to accelerate our provision and commitment to the UK's pharmaceutical industry and healthcare stakeholders.
With the acquisition of Fourth Hurdle, we are further building upon the expertise of IMS' global HEOR capabilities, and together with our team based in Hammersmith, London, we now present clients with the largest and most comprehensive HEOR team in the UK. Additionally, as part of the Pricing and Market Access practice IMS has the unique capability to deliver integrated global market access strategy and implementation programs.
As specialists in the application of economics to healthcare, the team at Fourth Hurdle supports the needs of all involved in the health technology business, from top-level strategy to development and application of economic analysis and communication of health outcomes information.
Fourth Hurdle joins over 170 HEOR specialists within the IMS Consulting and Services business, a team amassed through a series of strategic acquisitions, which recently included local-market experts like Aremis in France; MERG in Germany and ValueMedics in the U.S.
As a result of this union, we are confident that the combined capabilities and expertise of IMS and Fourth Hurdle will provide clients with an even stronger, broader range of solutions to support their businesses.
If you have any questions about this exciting development, please do not hesitate to call us on the numbers below.
David Grant, Pippa Anderson & Adam Lloyd
Senior Principals HEOR
Tel: +44 (0)20 7440 4060
Jon Resnick
VP and Practice Leader Pricing and Market Access
Tel: +44 (0)1223 273436